Skip to content

Pharmacogenetic Supported Prescribing in Kids

Mental Health Impairment

Implementation of pharmacogenetic testing for children and adolescents aged 6-24 who are starting or changing psychiatric medication.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    6 to 24

Critères de participation

Inclusion Criteria:

* Medical records available
* The initiation, change, dose adjustment, or augmentation of psychiatric medication(s) is indicated
* Treating psychiatrist, family physician, or pediatrician licensed in Alberta, British Columbia, Saskatchewan, or Manitoba requests pharmacogenetic testing

Exclusion Criteria:

* Medically unstable or lacking capacity to provided informed consent
* Unwillingness of child to provide saliva sample for genetic analysis
* History of liver or bone marrow (hematopoietic cell) transplant

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Laina McAusland, MSc

[email protected]
403-210-6353
Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: NCT04797364